Health
Trial results favor prasugrel over ticagrelor after coronary stenting
Headline as filed by Medical Xpress. PageNews does not write or rewrite headlines.
PageNews Brief
One publisher, Medical Xpress, has reported this so far, at 14:00 UTC on 31 August 2026.
No other outlet PageNews follows has covered it. If one files, their report will be added to this page and the comparison below will fill out.
The coverage is filed under Health. The publisher's own headline, summary and link is below.
Compiled by PageNews from the report listed below — who filed it and when. No publisher wrote this section.
Coverage from 1 publisher
-
Medical Xpress
Trial results favor prasugrel over ticagrelor after coronary stenting
Prasugrel reduced major cardiovascular events to the same extent as ticagrelor but with lower major bleeding after coronary stenting in patients with acute coronary syndromes, according to results fro
Read on Medical Xpress →
Reader comments
Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.
Nobody has commented on this story yet.